SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 12:11 PM ETAbout this dataData status
$27.39▼-1.08 (-3.79%)
After Hours:$28.99+1.60 (+5.84%)· 12:11 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.6 · elevated volatility

Overview →
Next report

Feb 11 2027in 84 days

EPS estimate

($0.45)

Revenue estimate

$1M

EPS beats

1 of last 2

Earnings SurpriseEPS, actual vs estimateLatest +0.0%

How far reported EPS beat (+) or missed (−) the analyst estimate that stood when each report landed.

2026: -1306.1%2026: 0.0%0.0%
Aug 13 2026Nov 12 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Nov 12 2026($0.36)($0.36)+0.0%$375000$2M+463.7%
Aug 13 2026($0.17)($2.32)-1306.1%$17M$100000-99.4%
May 19 2026—($0.72)————

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+108.33%
EPS—
FY2028
Rev-67.50%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$5M$10M$3M
Low$4M$9M$3M
High$5M$11M$4M
EBITDA Avg$-299M$-212M$-219M
Low$-351M$-231M$-228M
High$-247M$-193M$-210M
EBIT Avg$-301M$-214M$-220M
Low$-353M$-232M$-229M
High$-249M$-195M$-211M
Net Income Avg$-302M$-215M$-222M
Low$-354M$-234M$-230M
High$-250M$-196M$-213M
EPS Avg$-2.56$-1.82$-1.88
Low$-3.00$-1.98$-1.95
High$-2.12$-1.66$-1.80
Analysts (Rev / EPS)2 / 33 / 34 / 2
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$1M$2M$2M$3M$3M
Low$1M$2M$2M$3M$3M
High$1M$2M$2M$3M$3M
EBITDA Avg$-51M$-47M$-49M$-50M$-51M
Low$-59M$-47M$-49M$-50M$-51M
High$-42M$-47M$-49M$-50M$-51M
EBIT Avg$-51M$-47M$-49M$-50M$-51M
Low$-59M$-47M$-49M$-50M$-51M
High$-42M$-47M$-49M$-50M$-51M
Net Income Avg$-51M$-48M$-49M$-50M$-52M
Low$-59M$-48M$-49M$-50M$-52M
High$-42M$-48M$-49M$-50M$-52M
EPS Avg$-0.41$-0.39$-0.40$-0.41$-0.42
Low$-0.48$-0.39$-0.40$-0.41$-0.42
High$-0.34$-0.39$-0.40$-0.41$-0.42
Analysts (Rev / EPS)2 / 22 / 11 / 11 / 11 / 1

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.